Health Products

Recall of Cannabis for Medical Purposes – Aphria

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Labelling and Packaging
Audience: General Public
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberTelephoneBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
The following lots are classified under the Type III recall initiated on January 25, 2018.1-844-427-4742
Marketing Authorization Holder
Not Applicable
Dried marijuana
Recalling Firm
Aphria
Ontario
CANADA
Not ApplicableNot Applicable22.21% THC,

Introduction

Introduction

On January 25, 2018, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary Type III recall of two lots of dried marijuana that were produced between January 19 and January 22, 2018. The affected lot number(s) are found below.

Reason

On January 25, 2018, Aphria initiated a voluntary Type III recall for two lots of dried marijuana sold in 10 g bottles, due to a labelling error. The labels omitted to indicate the percent sign (%) next to the numerical values for cannabinoid content.

A Type III recall refers to a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and contact Aphria at the following number 1-844-427-4742.

Media enquiries

Health Canada
(613) 957-2983
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime